Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Nicotine in Schizophrenic Smokers
NCT00218218Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jun 2002
- Primary completion
- Feb 2005
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Started Jun 2002; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00218218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218218.